BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/06/2024

FDA Clears INVEGA Extended-Release Tablet for Continued Approval

The FDA has determined that INVEGA (paliperidone) extended-release tablet, 1.5mg, was not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) that refer to the product.

Source: Federal Register — Food and Drug AdministrationOpen original release →